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cyclase using a photoswitchable peptidic
hormone†
Tom Podewin, ‡§a Johannes Broichhagen, ‡§a Christina Frost, b
Dieter Groneberg, c Julia Ast, de Helena Meyer-Berg, a Nicholas H. F. Fine, de
Andreas Friebe, c Martin Zacharias, b David J. Hodson, de Dirk Trauner *a
and Anja Hoﬀmann-Ro¨der *a
The optical control over biological function with small photoswitchable molecules has gathered signiﬁcant
attention in the last decade. Herein, we describe the design and synthesis of a small library of
photoswitchable peptidomimetics based upon human atrial natriuretic peptide (ANP), in which the
photochromic amino acid [3-(3-aminomethyl)phenylazo]phenylacetic acid (AMPP) is incorporated into the
peptide backbone. The endogeneous hormone ANP signals via the natriuretic peptide receptor A (NPR-A)
through raising intracellular cGMP concentrations, and is involved in blood pressure regulation and sodium
homeostasis, as well as lipid metabolism and pancreatic function. The cis- and trans-isomers of one of our
peptidomimetics, termed TOP271, exhibit a four-fold diﬀerence in NPR-A mediated cGMP synthesis in
vitro. Despite this seemingly small diﬀerence, TOP271 enables large, optically-induced conformational
changes ex vivo and transforms the NPR-A into an endogenous photoswitch. Thus, application of TOP271
allows the reversible generation of cGMP using light and remote control can be aﬀorded over vasoactivity
in explanted murine aortic rings, as well as pancreatic beta cell function in islets of Langerhans. This study
demonstrates the broad applicability of TOP271 to enzyme-dependent signalling processes, extends the
toolbox of photoswitchable molecules to all classes of transmembrane receptors and utilizes
photopharmacology to deduce receptor activation on a molecular level.Introduction
Controlling biological function with light has been achieved
using two general approaches, viz. optogenetics1 and photo-
pharmacology.2,3While the rst relies on the genetic introductionntegrated Protein Science, LMU Munich,
ny. E-mail: anja.hoﬀmann-roeder@cup.
y of Munich, James-Franck-Str. 1, 85748
titute of Physiology, Ro¨ntgenring 9, 97070
(IMSR) and Centre of Membrane Proteins
ingham, Edgbaston, B15 2TT, UK
etabolism, Birmingham Health Partners,
(ESI) available: Details on solid phase
all peptides can be found here, as well
s, aortic tensometry, islet treatment,
modelling and simulations. See DOI:
r medical research (MPImF), Jahnstrabeof light-responsive proteins, the latter describes the exogenous
use of small photochromic molecules that interact with a specic
target. The advantage of photopharmacology is the precise
control of cell signalling through native receptors, without
necessarily introducing foreign genes. While optogenetics has
successfully targeted the receptor-linked enzyme (RLE) class,4 in
particular receptor tyrosine kinases,5,6 photopharmacology has
not kept pace. One reason is that RLE ligands are usually large
peptides with few known small molecule activators, making it
a challenge to nd a suitable “azologable”3 pharmacophore.
However, we and others recently reported the optical control of
cell function with photoswitchable peptides,7,8 an approach that
is highly applicable to RLEs.
Accordingly, we focused on the natriuretic peptide receptor A
(NPR-A), with its endogenous agonist atrial natriuretic peptide
(ANP), as a suitable target for RLE photocontrol (Fig. 1a). The
physiological actions of ANP are widespread and range from
blood pressure regulation and sodium homeostasis to eﬀects on
fat metabolism and pancreatic beta cell function/survival.9–11 ANP
is mainly expressed and stored as inactive proANP in atrial
cardiac myocytes, with lesser concentrations found in the
ventricles and kidneys. Upon secretion, primarily controlled by
mechanical stimulation following atrial wall stretching,12,13This journal is © The Royal Society of Chemistry 2017
Fig. 1 ANP receptor and AMPP. (a) The ANP receptor links photo-
switchable peptide binding to activation of guanylyl cyclase, that
is cGMP generation and subsequent vasodilation in its UV-light
adapted cis-state. (b) The photoswitch AMPP can be toggled between
its trans- and cis-isomer with blue (460 nm) and UV-light (365 nm),
respectively. (c) Initial assessment of AzoANP peptides TOP263-
271 potency towards cGMP synthesis focuses on TOP271, where
four amino acids are replaced on the C-terminal side of the
macrocycle.
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View Article OnlineproANP is rapidly cleaved by the cardiac serine protease corin to
release the active 28 amino acid ANP.14 The active form comprises
a central 17 amino acid macrocycle linked by a disulde bridge
between Cys7 and Cys23. Following ligand activation of NPR-A,
the membrane-proximal regions of the monomeric receptor
units undergo a global conformational change, triggering gua-
nylyl cyclase activity. This leads to generation of cGMP, a major
player in intracellular cell signalling.12
Dysregulated ANP secretion has been linked to diﬀerent
cardiovascular diseases, i.e. atrial brillation,15 hypertension16,17
and heart failure.18,19 Moreover, genetic variants in or close to
the ANP gene (NPPA) locus, which lead to increased circulating
levels of plasma ANP, were shown to lower blood pressure andThis journal is © The Royal Society of Chemistry 2017the risk of hypertension in healthy individuals.20,21 Further-
more, individuals harbouring one copy of the G allele of rs5068
have lower likelihood of diabetes,22 and ANP has been shown to
increase muscle insulin sensitivity,23 although whether insulin
release itself is stimulated is more debated.10,11,24 Such funda-
mental and pleiotropic actions of ANP have made its receptors
an important pharmacological target, resulting in recently
introduced therapies for the treatment of cardiovascular
diseases.25,26 Despite this, many facets of ANP function and
action remain elusive. Thus, the development of novel tools for
unravelling and controlling ANP/NPR-A-stimulated signalling
processes would be a valuable asset.
To address this, we report the synthesis of a photochromic
ligand based on human ANP that enables the photocontrol of
RLE activity (Fig. 1a). The NPR-A was endowed with light-
sensitivity by incorporation of the photoswitchable amino
acid [3-(3-aminomethyl)phenylazo]phenylacetic acid (AMPP)27,28
into ANP, which along with related derivatives,8,29–31 has proven
to be a valuable building block for photocontrol of peptide
conformation and activity (Fig. 1b). One out of nine of our
synthesised photochromic ANPs (AzoANPs), termed TOP271,
allowed optical control to be exerted over NPR-A activity, intra-
cellular cGMP levels, and downstream processes using UV and
blue light.
Results and discussion
Our initial design approach was based on the incorporation of
AMPP into the peptidic backbone of ANP, to induce maximal
structural changes upon photoisomerisation. Nine diﬀerent
photochromic AzoANP peptides (dubbed TOP263-271) were
designed and synthesised to obtain a small library (Fig. 1c),
whereby AMPP replaced two, three or four amino acids in ANP.
These numbers were based on our experience with other
peptides, in which AMPP displaced two amino acids and the
fact that AMPP covers up to four amino acids in length.8,28 The
substitutions, following a circular permutational fashion, were
located either near the N- or C-terminus or facing the Cys7-
Cys23 disulde bridge in the native 17 amino acid cycle of
ANP (see ESI† for details on synthesis and characterization).
For the incorporation of azobenzenes into cyclic peptides
several approaches have been developed in recent years. They
range from synthesis and screening of small peptide libraries to
combinatorial approaches utilising phage selection for the in
vitro evolution of photoswitchable ligands.32–35 We selected
amore rational design approach, in which the substitution sites
were selected based on perceptions of ANP binding to NPR-A
from mutational and structural studies.36–38 Upon ANP
binding, the NPR-A receptor forms a homodimer, where the
ligand is buried between the two extracellular domains of the
respective monomers. The binding of ANP is asymmetric and
one domain interacts mainly with the N-terminal, while the
other interacts with the C-terminal part. Important binding
interactions involve Phe8, Arg14 and Asn24 of ANP. Phe8
extends to and interacts with a hydrophobic binding pocket,
which is critically important for hormonal activity. Arg14 forms
hydrogen bonds with both monomers (Asp 62 and Glu119),Chem. Sci., 2017, 8, 4644–4653 | 4645
Fig. 2 TOP271 photodynamics and cGMP concentration-responses.
(a) UV/Vis spectra of cis- and trans-TOP271. (b) Reversible switching of
TOP271 with UV (365 nm) and blue (460 nm) light. (c) Bistability of
TOP271 when switched to the cis-isomer by means of UV light (365
nm) and subsequently left in the dark. (d) Concentration-response
curves of cis- and trans-TOP271 in NPR-A transfected HEK293T cells
assessed by cGMP HTRF, 30 min incubation time. EC50 values for ANP
¼ 2.0 0.4 nM, cis-TOP271¼ 127 11 nM and trans-TOP271¼ 468
59 nM correspond to two independent assays. Values represent the
mean  SEM.
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View Article Onlinestabilizing the partially open dimer interface. The C-terminal
located Asn24 forms two hydrogen bonds that are important
for receptor binding and hormone activity.38
Thus, the substitution schemes either involved the direct
replacement of the important binding residue, as in the case of
N-terminal substitution, or located AMPP close to it, as for the
C-terminal and middle substitution schemes. By substituting
Phe8 with AMPP, it was envisaged that in these peptides the
hydrophobic photoswitch would diﬀerentially engage the
hydrophobic pocket in its cis- or trans-form, modifying receptor
binding and hormone activity. We dismissed the design of
peptides in which AMPP was placed adjacent to Phe8, i.e.
through substitution of residues Gly9 – Met12, due to the
possibility of aromatic stacking. In the peptides with the middle
substitution scheme, AMPP was placed adjacent to Arg14, to
control the hydrophilic interactions of this residue with the
receptor. In the N-terminal substitution scheme, AMPP was
placed in the ring alongside Cys23 and the disulde bridge. In
these peptides, isomerisation should not only shi the ring
structure, but also alter the binding interactions of Asn24 to
domain B of the dimerised NPR-A receptor.
At this point, it is worth noting that initial screening of cGMP
accumulation returned a single compound, i.e. TOP271, as
being the most active and most isomer-dependent peptide.
Thus, we focused on characterisation and investigation of this
lead compound and further details on the cGMP assays can be
found under “optical control of cGMP generation”. Although
our design approach was restricted to nine peptides, with many
possible patterns being omitted, it led to the isolation of the
functional compound TOP271. This not only validates our
rational design strategy, but also conrms the targeting of ANP/
NPR-A interactions for the control of receptor binding and
activation.Photophysical properties of AzoANP peptides TOP263-271
The photochromic AzoANP peptides including native human
ANP (hsANP) were synthesised through solid-phase peptide
synthesis (SPPS), characterized by high resolution mass spec-
trometry, and their purity assessed by reverse-phase HPLC: all
were <3.7 ppm of the calculated mass and RP-HPLC revealed
high purity (see ESI† for MS and HPLC data). The switching
kinetics of all “azologued” peptides were determined by UV/Vis
spectroscopy (TOP271 Fig. 2a–c, TOP263-270 ESI Fig. 1–3 and
ESI Tables 1 and 2†). Starting with compounds in the dark-
adapted state (vide infra), a decrease in the p–p* and an
increase in the n–p* band was observed in response to UV light
(l ¼ 365 nm) (Fig. 2a), with reversion of this switching process
in response to blue light (l ¼ 460 nm).
As expected for an electron-poor azobenzene, all peptides
were bistable (TOP271 Fig. 2c, TOP263-270 ESI Fig. 3†).{ This
advantageous trait allows samples to be pre-illuminated prior to
application rather than needing constant illumination. We
determined the thermal cis/ trans relaxation rate kobs in PBS
buﬀer. This was performed at room temperature, and because
the compounds were bistable, the initial back-relaxation was
obtained as a linear function from the rst 30 min aer ceasing4646 | Chem. Sci., 2017, 8, 4644–4653illumination. Peptides TOP263-270 showed kobs 104 a.u.330 nm
min1 between 0.28–2.83, with the most potent compound
TOP271 being 0.98 a.u.330 nm min
1 (see ESI Table 2,† compare
with kobs ¼ 3.58  104 a.u. min1 for unsubstituted azo-
benzene in benzene at 0 C).39 To examine the structural rela-
tions between ANP and both isomers of TOP263-271, CD
spectra were recorded in 40% buﬀered aqueous 2,2,2-tri-
uoroethanol (TFE) solutions. TFE is needed for the peptides to
form stabilised secondary structures instead of random coils,40
and the optimal TFE concentration of 40% was determined
with ANP in diﬀerent aqueous buﬀered mixtures (ESI Fig. 4a†).
The spectra of the peptides TOP263-271 showed diﬀerences
between their cis/trans-isomers, but remained similar to that of
native ANP, with no observable trend (ESI Fig. 4b and c†).
TOP271 was subjected to further characterisation for both its
cis- and trans-form by NMR spectroscopy alongside ANP. The
spectra were recorded in 35% aqueous TFE-d3 solutions to
suppress signal broadening and aggregation (see ESI† for NMR
data on ANP and cis/trans-TOP271). The cis-TOP271 NMR
spectrum showed overlapping signals and thus could not be
resolved. Nevertheless, the 1H and 13C chemical shi values of
the trans-TOP271 peptide could be unambiguously identied,
showing the incorporation of AMPP into the backbone of the
peptide and the overall correct structure.
Optical control of cGMP generation
To assess the most suitable peptide for further analysis, cGMP
generation was measured in HEK293T cells transientlyThis journal is © The Royal Society of Chemistry 2017
Fig. 3 TOP271 allows photocontrol of aortic tissue. (a) Concentration-
response curves for trans- and cis-TOP271. (b) Aortic relaxation for
cycles in (d) and (e). (c) s of aortic relaxational responses for 17 nM ANP
compared to 400 nM trans- and cis-TOP271. (d, e) Reversible pho-
tocontrol over aortic tension by application of trans-TOP271 (d) and
cis-TOP271 (e) with UV-/blue and blue/UV-light (365 and 460 nm)
cycles, respectively. All experiments were conducted in the presence
of 200 mM N-u-nitro-L-arginine methyl ester (L-NAME) and 3 mM
diclofenac, which were used to block the vascular relaxants nitric
oxide and prostacyclin, respectively. PE ¼ phenylephrine was used for
initial vasoconstriction, IBMX ¼ 3-iso-butyl-1-methylxanthine was
used to induce complete muscular relaxation as an end point control.
(n ¼ 6 aortic rings from 4 animals) (*P < 0.05, **P < 0.01, repeated
measures Student's t-test). Values represent the mean  SEM.
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View Article Onlinetransfected with NPR-A.41 cGMP is a major eﬀector of cellular
metabolism,42 with eﬀects on adipose tissue,43–45 liver46,47 and
the brain.48 Alongside nitric oxide, the natriuretic peptides are
the major potentiators of cGMP generation, with downstream
signalling eﬀects on phosphodiesterases (PDEs),49 cGMP-
dependent proteinkinases (PKGs)50 and cyclic nucleotide-gated
channels (CNGs).51 ANP induces smooth muscle relaxation
through increases in intracellular cGMP levels and activation of
PKGI, which subsequently leads to a decrease in cytosolic Ca2+
levels and reduced Ca2+-sensitivity of the contractile
system.12,52,53 Furthermore, depleting cGMP levels leads to
depolarization in rods of the retina, triggering action potentials
that transduce signals to perceive light.54
To test cGMP synthesis, each peptide was applied as the
trans- or cis-isomer by keeping them either in the dark or pre-
illuminating with UV light (l ¼ 365 nm) for 15 minutes,
respectively. Using this approach, TOP271, i.e. the ANP
analogue where AMPP replaces four amino acids at the C-
terminal end of the ring, was identied as the most prom-
ising candidate due to its highest binding aﬃnity. In addition,
a trend in the activity of these azobenzene-containing peptides
was revealed: activity towards cGMP synthesis was higher the
more amino acids were replaced and the closer their substitu-
tion was located to the N-terminus (Fig. 1c). Besides TOP271,
only three further peptides from our small AzoANP library,
TOP264, 265 and 268, showed NPR-A activation in the mM
range (ESI Fig. 5†). The low potency of these compounds and
the inactivity of the remaining photochromic ANP peptides
(TOP263, 266, 267, 269 and 270) likely stems from the
substitution of residues crucial for receptor binding, such as
Phe8.55,56
With TOP271 as the lead candidate, we attempted to access
light-dependent NPR-A activity. The measured cGMP
concentration-responses showed that both TOP271 isomers had
similar potency to native ANP (EC50 ¼ 2.0  0.4 nM) (Fig. 2d),
but cis-TOP271 (EC50 ¼ 127  11 nM) was roughly four times
more potent than the trans-isomer (EC50 ¼ 468  59 nM). Since
these EC50 values correspond to the maximum incubation time
of 30 minutes, we wanted to assess the time-dependency of
potency and isomer-biased receptor activation. Therefore, we
collected further data with shorter incubation times, which
showed uctuations for the ANP/TOP271 potency diﬀerence
(ESI Fig. 6, ESI Table 3†). Nevertheless, the diﬀerence in potency
between cis- and trans-TOP271 was robust and reproducible.
cGMP competition assays between ANP and cis/trans-TOP271
showed right-shied EC50 values for ANP, as expected when
ligands compete for the same binding site (ESI Fig. 6†).
Although cGMP end point assays do not provide direct evidence
for ligand-mediated NPR-A over intracellular GC-A activation,
this screening shows clear competition. Given the fact that ANP
is well characterised to activate NPR-A, we assume that extra-
cellular activation is key to cGMP generation. However, further
studies are required to conclusively understand whether
TOP271 directly activates GC-A, for instance using FRET-based
reporters.
It should also be noted that, although the increase in EC50
seems small, signal integration and amplication of cGMPThis journal is © The Royal Society of Chemistry 2017leads to more pronounced responses in cellulo.57 With this in
mind, we decided to progress TOP271 through to more relevant
studies ex vivo.
Optical control of smooth muscle tone and pancreatic beta
cell function
We next sought to address whether TOP271 would allow the
optical control of cGMP-dependent processes in a physiologi-
cally relevant system, i.e. the aortic ring preparation. The
treatment of constricted aortic rings with ANP leads to a potent
vasodilation, corresponding to the blood pressure reducing
eﬀect of ANP.58 Accordingly, we predicted that TOP271 would
allow reversible, light-controlled vasoactive responses, with cis-
TOP271 being the stronger eﬀector at specic concentrations.
Concentration–response curves were obtained for vasodilation
in pre-constricted aortic rings following exposure to pre-
illuminated cis- (l ¼ 365 nm) and trans-TOP271 (l ¼ 460 nm),
and showed increased potency for the former isomer in the
100 nM to 1 mM range (Fig. 3a, ESI Fig. 7†). Although this
concentration–response indicated a signicant diﬀerence in
receptor activation for 100 nM TOP271, we decided to use
400 nM TOP271 to trigger a stronger isomer-dependent vaso-
dilation. Thus, the application of dark-adapted trans-TOP271
led to strong vasodilation, which was enhanced following UV
(l ¼ 365 nm) illumination to induce cis-isomerisation, and
again reversed aer blue light (l ¼ 460 nm) exposure to induce
trans-accumulation (Fig. 3b and d, ESI Fig. 8†).Chem. Sci., 2017, 8, 4644–4653 | 4647
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View Article OnlineConversely, to examine the cis/ trans/ cis isomerisation
cycle, pre-illuminated (l¼ 365 nm) cis-TOP271 was added to the
organ bath, leading to a potent vasodilation (Fig. 3b and e).
Subsequent trans-isomer accumulation by exposure to blue
light (l ¼ 460 nm) elicited vasoconstriction, which again could
be reversed by UV (l¼ 365 nm) illumination. Notably, the speed
of the initial vasodilation was 1.5 higher for cis- compared to
trans-TOP271, with the former being analogous to ANP (Fig. 3c).
Although the experimental setting limited TOP271 switching to
three iterations, isomerisation is robust and extended switchingFig. 4 TOP271 allows photocontrol of pancreatic beta cell function. (a–
d) ANP concentration-dependently suppresses Ca2+ responses in beta
cells (representative traces shown) (scale bar 25 mM) (n ¼ 4–6 islets for
each concentration) (**P < 0.01, one-way ANOVA). (e–h) cis-TOP271
concentration-dependently inhibits Ca2+ spike amplitude, whereas
trans-TOP271 is less eﬀective at all concentrations tested (representative
traces shown) (scale bar 25 mM) (n ¼ 4–6 islets for each concentration)
(**P < 0.01, two-way ANOVA). (i and j) TOP271 allows reversible pho-
tocontrol of beta cell function, with blue (458–488 nm) light partially
restoring Ca2+ responses (n ¼ 5 islets) (*P < 0.05, repeated measures
one-way ANOVA). Values represent the mean  SEM.
4648 | Chem. Sci., 2017, 8, 4644–4653cycles are conceivable depending on the application, where
degradation and clearance together with internalization and
desensitization can play roles in repeated switching eﬃciency.
Still, the multiple switching of TOP271 facilitates the imple-
mentation of this compound to induce desired vasoactive
eﬀects locally, within a spatially conned area. This clearly sets
TOP271 apart from other agonists or inhibitors, which in
general only allow for systemic application.
Insulin-secreting pancreatic beta cells express NPR-A, and
ANP action is thought to provide a potential explanation for the
association between cardiovascular and metabolic dysregula-
tion.59,60 We observed that native ANP concentration-dependently
(0.1–100 nM) suppressed beta cell function at physiologically-
elevated glucose (8 mM) levels, as shown by a reduction in the
amplitude of intracellular Ca2+ uxes in intact islets of Langer-
hans (Fig. 4a–d). These ndings could be replicated using UV pre-
illuminated (l ¼ 365 nm) cis-TOP271 (Fig. 4e–h), which also
robustly suppressed Ca2+ rises from 1–100 nM. By contrast, dark-
adapted trans-TOP271 induced only a small decrease in beta cell
Ca2+ spiking activity (Fig. 4e–h). Reversibility could be achieved
by applying cis-TOP271 and then illuminating with blue light (l¼
458–482 nm) to induce trans-isomerisation (Fig. 4i and j).
Restoration of beta cell function was only partial (Fig. 4j),
however, possibly due to cGMP-mediated sequestration of Ca2+
into internal stores such as the endoplasmic reticulum.61
Pancreatic beta cells have been shown to express NPR-A, and
links exist between ANP and diabetes risk.62 Indeed, ANP gene
expression is increased in the ventricles of rats with reduced
beta cell mass, and ANP levels are elevated during diabetes.59
The eﬀects of ANP on beta cell function are complex and
controversial. While some studies have shown that ANP
decreases Ca2+ levels and insulin secretion,10,24 others have
shown stimulatory eﬀects.11,63 This likely reects diﬀerences in
the time course of application, preparation under examination
(i.e. dissociated vs. intact islets), stimulation state (i.e. low vs.
high glucose) and concentration. With regards to the latter, we
were able to show a bimodal relationship where low doses of
ANP preferentially aﬀect Ca2+ oscillation frequency without
altering amplitude, whereas high doses do the opposite (ESI
Fig. 9†). Thus, TOP271 may provide an important tool to allow
ANP receptor conformation and signalling to be understood in
the context of beta and other cell (dys)function.Molecular dynamics simulations of ANP and cis/trans-TOP271
Atomic-level modelling in explicit solvent was conducted to
better understand the structure-activity relationships of isomer-
dependent NPR-A activation. We focused on the in silico struc-
ture of native ANP peptide and cis/trans-TOP271, both in
aqueous solution and bound to the NPR-A receptor. The extra-
cellular domains were modelled based on the NPR-A crystal
structure (PDB: 1t34, in complex with rat ANP (rnANP)),55 while
the receptor-bound ANP peptide and the cis/trans-TOP271
isomers where based on the NPR-C crystal structure (PDB: 1yk0,
in complex with human ANP).56 We used the latter for our
structural peptide modelling to account for the Met12/Ile12
diﬀerence between ANP and rnANP, respectively.This journal is © The Royal Society of Chemistry 2017
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View Article OnlineIn a rst step, the cis/trans-TOP271 isomers were simulated
for 200 ns in the absence of the NPR-A receptor. To compare the
aﬃnity of both isomers to adopt the bound ANP ring structure,
distance restraints with respect to the ANP crystal structure were
applied between all Ca-atom pairs within the ring, neglecting
the two terminal tails. The resulting restraint energy distribu-
tions show a clear diﬀerence between the isomers (Fig. 5a), with
the energy of trans-TOP271 being on average 6.7 kcal mol1
higher. This likely derives from the rigid, extended trans-azo-
benzene structure, which sterically prevents adoption of the
native ring structure (Fig. 5b).
To elucidate the eﬀect of the isomeric conformational diﬀer-
ences on receptor geometry, unrestrained simulations of 1 ms
length were performed for NPR-A bound to cis/trans-TOP271, ANP
and apo-NPR-A. The overall receptor RMSD signicantly diﬀers
for cis- and trans-TOP271, with the former matching ANP and the
latter being similar to apo-NPR-A (Fig. 5c). These isomer-
dependent diﬀerences in receptor geometry are related to
a change in relative orientation of the two NPR-A dimers: while
there are no ligand-dependent orientation changes in the
membrane-distal domains (ESI Fig. 10a†), the membrane-
proximal domains tend to close around ANP and cis-TOP271,
but remain more open in the case of trans-TOP271 (Fig. 5d–g).
This is in agreement with the crystal structures of the diﬀerent
apo- and ligand-bound natriuretic peptide receptors, which show
up to 20 A˚ distance change between the two C-terminal/
membrane-proximal receptor domains upon ligand binding.55,56Fig. 5 MD simulations of ANP and TOP271. (a) Restraining energy distribu
solution, including restraints to keep the sampled conformations close to
cis- and trans-TOP271 illustrating the steric hindrance of trans-azobenze
Cys23 disulﬁde bridge). (c) Mean backbone-Ca RMSD and standard devia
ms simulation, calculated for bound native ANP (black), bound cis/trans-T
receptor RMSD clearly diﬀers between native and cis-TOP271 vs. trans-T
arrow) of the membrane-proximal NPR-A domains after 1 ms simulatio
domains tend to close compared to trans-TOP271 and the apo-NPR-A (b
for bound native ANP (e) and bound cis/trans-TOP271 (f and g, respective
site coverage visualised by time-superposition of the disulﬁde-connect
#1000 ns). Middle row: zoom into the time-superposition illustrates diﬀe
vs. trans-TOP271 (azobenzene in line design). Bottom row: representativ
azobenzene, orange: Cys7-Cys23 disulﬁde bridge).
This journal is © The Royal Society of Chemistry 2017trans-TOP271 thereby resembles the apo-form, in which uctu-
ating membrane-proximal distances shi the receptor towards
an open state (Fig. 5c). These changes in receptor geometry can
be assigned to isomeric diﬀerences in the bound conformation.
Whereas the preferred conformations of cis-TOP271 are compa-
rable to the crystal ring structure of ANP, the conformational
ensemble of trans-TOP271 is narrower and more hairpin-like
(Fig. 5e–g). The NPR-A-bound crystal structure of ANP also
reveals a central pore in the 17 amino acid ring that is essential
for ligand binding; only cis-TOP271 is able to adapt this
donut-like conformation, while the trans-isomer forms a closed
structure (Fig. 5e–g).
Lastly, we attempted to quantify the twist motion of the NPR-
A membrane-proximal domains upon ligand binding, which is
thought to initiate intracellular GC activation.55 Here, we
detected a less prominent isomer dependency for the selected
twist angle of the ligand-bound receptor domains compared to
apo-NPR-A (see ESI Fig. 10b and ESI Table 3†). While the
binding of ANP leads to a focusing of the twist angle distribu-
tions in NPR-A, bound cis- and trans-TOP271 show broader,
shied distributions and the apo-NPR-A inherits large angle
uctuations. This shows on the one hand the higher similarity
of angle distributions of ANP and cis-TOP271 compared to trans-
TOP271, but on the other hand also the exibility of the apo-
NPR-A membrane-proximal regions. Notably, crystal structures
represent only a structural snapshot, while MD simulations
cover a whole ensemble of structures and as a result wetion obtained fromMD simulations (200 ns) of cis- and trans-TOP271 in
native ANP (see ESI†). (b) Representative restrained conformations of
ne to ﬁt into the native ring structure (red: azobenzene, orange: Cys7-
tion of the NPR-A dimer and the both receptor domains A and B after 1
OP271 (gray and blue, respectively) and apo-NPR-A (cyan). The overall
OP271 and apo-NPR-A. (d) Center-of-mass distance (orange balls and
n. For bound native ANP (black) and cis-TOP271 (gray) the receptor
lue and cyan). (e–g) Representative NPR-A and peptide conformations
ly). Top row: isomer-dependent overall receptor geometry and binding
ed isomer segment Cys7-Cys23 (red: #300 ns, white #600 ns, blue
rences in the conformational ensemble of native ANP and cis-TOP271
e isomer conformations extracted from the simulated ensemble (red:
Chem. Sci., 2017, 8, 4644–4653 | 4649
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View Article Onlineconclude that the reduced distance between the membrane-
proximal domains in the ligand-bound state, and not the
twisting motion of the NPR-A, is the major trigger for receptor
activation.
In summary, our MD simulations showed a higher exibility
of the apo-NPR-A and the trans-TOP271-NPR-A receptor
complex, whereas the membrane-proximal receptor domains
tend to close around ANP and cis-TOP271. The simulations
hence suggest an alternative regulation of guanylyl cyclase
activity, in which the binding of ANP and cis-TOP271 to NPR-A
suppresses dynamic uctuations of the membrane-proximal
domains of both receptor dimers, leading to dened ligand/
receptor structures.Conclusions
In this study, we present the design, synthesis, evaluation and
application of TOP271, a peptidic hormone based on ANP with
a photoresponsive azobenzene unit. Acting via the NPR-A
receptor to generate cGMP, TOP271 allows the reversible photo-
control of contraction/dilation in aortic tissue, as well as Ca2+
oscillations in rodent islets of Langerhans. Although photo-
dependent cGMP synthesis was described earlier, these
approaches rely on the genetically-encoded photosensitive
proteins EROS64,65 or BeCyclOps,66,67 whereas TOP271 allows
unprecedented photocontrolled cGMP synthesis in native tissue.
EROS and BeCyclOps are based on bacterial avin-containing
photoreceptors and fungal rhodopsins, respectively, and can be
used to induce penile erection inmale rats or tactic behavior inC.
elegans following illumination. A drawback of EROS is the
residual cAMP activity, caused by the specic mutation of an
adenylyl cyclase to an engineered guanylyl cyclase. BeCyclOps on
the other hand utilizes native guanylyl cyclase activity and was
shown to specically engage only cGMP synthesis, but requires
genetic introduction. Photochromic ligands like TOP271 avoid
these issues and remain exogenously applied, thereby only tar-
geting and activating the protein of interest. It should be noted
that the stability of azobenzene compounds introduced ex vivo or
in vivo has to be evaluated on a case-to-case basis as degradation
of the diazene unit might occur depending on cell environment
or azoreductase expression. While we have shown that this is not
the case for polar compounds such as JB253 68 and JB558 69,
careful evaluation has to be performed before any clinical
applications can be envisioned.
With TOP271, we could selectively and reversibly manipulate
the NPR-A/cGMP signalling pathway with high spatio-temporal
precision. Interestingly, the 4-fold higher potency of cis-TOP271
for cGMP generation detected in vitro in transfected HEK293T
cells is suﬃcient to trigger a more pronounced vasodilation ex
vivo in aortic ring tissue. Although the exact intracellular cGMP
concentration is an active source of research eﬀorts, the
changes observed are in agreement to prior ndings, where
small changes in the concentration of this second messenger
provoke a signicant amplication of downstream signals.70 It
also showcases the robustness and applicability of TOP271,
which we believe will enable precise control of hemodynamic4650 | Chem. Sci., 2017, 8, 4644–4653processes, contributing to the dissection of vascular function in
health and disease.
Moreover, TOP271 not only demonstrates the successful
transformation of ANP into a photoswitchable peptide, but also
extends the toolbox of photochromic ligands to all classes of
transmembrane receptors. The incorporation of azobenzenes
into peptides and proteins has been achieved in a multitude of
systems in the last decade, i.e. in proteins of E. coli7,71 and in
short peptides with specic secondary structures such as b-
sheet and b-hairpin motifs.27,29,30,72 Two major possibilities
should be distinguished: (i) having an azobenzene as an amino
acid residue and (ii) having an azoswitch in the peptide back-
bone. While the former has been used to gain optical control
over binding aﬃnity of transcription factor and cell adhesion
molecules,71,73 the latter was successfully applied to the optical
control of muscle contraction31 and secondary structure
formation.74 We envision our design herein, together with
AzoChig28 and LirAzo,8 to be highly applicable to all kinds of
peptides (e.g. neuropeptides, such as oxytocin, vasopressin,
kisspeptin), as backbone substitution allows a larger confor-
mational change upon isomerisation and therefore a larger
change in aﬃnity and/or eﬃcacy. With recent synthetic eﬀorts
in mind,75 tetra-ortho-chloro-AMPP, exhibiting red-shied
switching wavelengths and high bistability, can be envisioned
for the incorporation into target peptides. Such breadth already
encompasses hairpin structures, a-helices and now macrocyclic
structures, but can potentially be extended to antibodies,
immunogens, peptidic hormones and receptors, where ne
regulation of protein function by tertiary structure stabilization/
destabilization is necessary for function.76 Thus, the present
ndings set the stage for photochromic peptides to become
a mainstay for optical control of biological processes using
photopharmacology.
Methods/experimental section
Experimental procedures and chemical characterization can be
found in the ESI.† Experimental protocols regarding live
animals were approved by the University of Birmingham's
Animal Welfare and Ethical Review Body (AWERB) and carried
out in accordance with the Animals (Scientic Procedures) Act
1986 of the United Kingdom.
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